Dyslipidemia [[electronic resource] /] / Ragavendra R. Baliga, Christopher P. Cannon

• Pubblicazione: Oxford ; ; New York, : Oxford University Press, 2012
• Descrizione fisica: 1 online resource (152 p.)
• Disciplina: 616.3/997; 616.3997
• Soggetto topico: Lipids - Metabolism - Disorders - Treatment; Atherosclerosis - Treatment; Coronary heart disease
• Soggetto genere / forma: Electronic books.
• Altri autori: BaligaR. R CannonChristopher P
• Note generali: Description based upon print version of record.
• Nota di bibliografia: Includes bibliographical references and index.
• Nota di contenuto: Cover; Contents; Contributors; 1 LDL Cholesterol; 2 HDL Cholesterol; 3 Non-HDL Cholesterol; 4 Use of High Sensitivity C-Reactive Protein for Risk Assessment; 5 Advanced Lipoprotein Testing: Assessment of Cardiovascular Risk and Therapy Beyond Standard Lipid Measurements; 6 Stratification of Dyslipidemic Risk; 7 Drugs for Treatment of Blood Lipoprotein Abnormalities; Index; A; B; C; D; E; F; G; H; I; J; K; L; M; N; O; P; Q; R; S; T; V; W; X; Z
• Sommario/riassunto: Dyslipidemia affects almost half of American adults and is the most prevalent manageable risk factor for atherosclerosis. Lipid disorders often co-occur with other prevalent conditions such as diabetes and kidney disease; they are also often a concern with certain medication regimens (such as anti-retroviral and certain anti-psychotic agents). Proper treatment of dyslipidemia can reduce the risk of peripheral arterial disease, revascularization procedures, nonfatal myocardial infarction, stroke, and cardiac death. However, only 20% of adults meet the national guidelines for cholesterol control
• Titolo autorizzato: Dyslipidemia
• ISBN: 1-283-57735-6; 9786613889805; 0-19-978037-4
• Formato: Materiale a stampa
• Livello bibliografico: Monografia
• Lingua di pubblicazione: Inglese
• Record Nr.: 9910465222303321
• Lo trovi qui: Univ. Federico II
• Serie: Oxford American Cardiology Library